Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-91.37%
operating margin TTM
-104.12%
revenue TTM
3.07 Million
revenue per share TTM
1.27$
valuation ratios | |
|---|---|
| pe ratio | -2.29 |
| peg ratio | 0.03 |
| price to book ratio | 2.97 |
| price to sales ratio | 2.10 |
| enterprise value multiple | -2.42 |
| price fair value | 2.97 |
profitability ratios | |
|---|---|
| gross profit margin | 53.48% |
| operating profit margin | -104.12% |
| pretax profit margin | -91.37% |
| net profit margin | -91.37% |
| return on assets | -58.15% |
| return on equity | -110.52% |
| return on capital employed | -116.13% |
liquidity ratios | |
|---|---|
| current ratio | 1.63 |
| quick ratio | 1.07 |
| cash ratio | 0.14 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 295.60 |
| operating cycle | 504.01 |
| days of payables outstanding | 87.73 |
| cash conversion cycle | 416.29 |
| receivables turnover | 1.75 |
| payables turnover | 4.16 |
| inventory turnover | 1.23 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.13 |
| debt equity ratio | 0.29 |
| long term debt to capitalization | 0.09 |
| total debt to capitalization | 0.23 |
| interest coverage | -21.53 |
| cash flow to debt ratio | -4.48 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.86 |
| cash per share | 0.48 |
| operating cash flow per share | -4.86 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -4.48 |
| short term coverage ratios | -6.98 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) reported earnings?
Ekso Bionics Holdings, Inc. (EKSO) published its most recent earnings results on 28-10-2025.
What is Ekso Bionics Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)'s trailing twelve months ROE is -110.52%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ekso Bionics Holdings, Inc. (EKSO) currently has a ROA of -58.15%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did EKSO's net profit margin stand at?
EKSO reported a profit margin of -91.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is EKSO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.63 in the most recent quarter. The quick ratio stood at 1.07, with a Debt/Eq ratio of 0.29.